BURNETT JOSEPH 4

4 · ClearPoint Neuro, Inc. · Filed Jul 1, 2026

AI-generated summary of this filing

Updated Jul 1, 2026

ClearPoint Neuro CEO Joseph Burnett Exercises Options, Sells Shares

What Happened

Joseph M. Burnett, CEO, President and a director of ClearPoint Neuro (CLPT), exercised 20,000 options at $2.50 per share (cost $50,000) and, on the same day (2026-06-29), sold 20,000 shares in an open-market transaction at a weighted average price of $19.38 for total proceeds of approximately $387,600. The filing also reports a 20,000-share derivative disposition listed at $0 (see footnotes for ownership/vesting details).
The sequence (exercise then same-day sale of an equal number of shares) functions effectively as a cashless exercise followed by a sale—i.e., Burnett did not retain those newly exercised shares as a long-term open-market holding.

Key Details

Transaction date: 2026-06-29; Form 4 filed 2026-07-01 (timely within required reporting window).
Exercise: 20,000 shares @ $2.50 = $50,000 paid.
Sale: 20,000 shares @ weighted avg $19.38 = ~$387,600 proceeds (sales ranged $19.15–$19.54 per F2).
Additional derivative disposition: 20,000 shares @ $0 reported (transaction code M; details not expanded in excerpt).
Shares owned after transaction: not provided in the excerpt of the filing.
Notable footnotes: trades were made under a Rule 10b5-1 trading plan adopted June 11, 2025 (F1); the shares are held by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Burnett as trustee (F3); vesting schedule for the option grant (Nov 7, 2017) is described (F4).

Context

This is a routine insider sale tied to option exercise and a prearranged 10b5-1 plan; sales like this do not necessarily signal a negative view of the company. Because the exercised shares were sold the same day, Burnett did not increase his public holding through this transaction.

Form 4

Period: 2026-06-29

DirectorCEO and President

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-06-29$2.50/sh+20,000$50,000→ 136,842 total
Sale
Common Stock
[F1][F2]
2026-06-29$19.38/sh−20,000$387,600→ 116,842 total
Exercise/Conversion
Stock Options (right to buy)
[F1][F4]
2026-06-29−20,000→ 250,000 total
Exercise: $2.50Exp: 2027-11-07→ Common Stock (20,000 underlying)

Holdings

Footnotes (4)

[F1]The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1.
[F2]Represents a weighted average sales price per share. The shares were sold at prices ranging from $19.15 to $19.54. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F3]These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
[F4]The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date. The grant date is November 7, 2017.

Signature

/s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett|2026-07-01

1 file